These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3609117)

  • 21. Dose-dependent kinetics of probenecid in rhesus monkeys--infusion studies.
    Chiang CW; Benet LZ
    Pharmacology; 1984; 28(4):181-7. PubMed ID: 6728896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability and pharmacokinetics of oxazepam.
    Sonne J; Loft S; Døssing M; Vollmer-Larsen A; Olesen KL; Victor M; Andreasen F; Andreasen PB
    Eur J Clin Pharmacol; 1988; 35(4):385-9. PubMed ID: 3197746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of the effect of probenecid on pharmacokinetics of 99mTc-mercaptoacetyltriglycine in dogs.
    Kakizaki T; Yokoyama Y; Natsuhori M; Yamada N; Hashimoto M; Sato K; Ito N; Daniel GB
    J Vet Pharmacol Ther; 2005 Dec; 28(6):559-64. PubMed ID: 16343289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers.
    Hedaya MA; Elmquist WF; Sawchuk RJ
    Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of probenecid on disposition kinetics of ampicillin in horses.
    Sarasola P; McKellar QA
    Vet Rec; 1992 Aug; 131(8):173-5. PubMed ID: 1413433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of cefotaxime and probenecid in sheep with normal and reduced renal function.
    Guerrini VH; Filippich LJ; English PB; Cao GR; Bourne DW
    J Vet Pharmacol Ther; 1984 Dec; 7(4):283-91. PubMed ID: 6096576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of single doses of cefoperazone given by the intravenous and intramuscular routes to unweaned calves.
    Soback S; Ziv G
    Res Vet Sci; 1989 Sep; 47(2):158-63. PubMed ID: 2799072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and elimination kinetics of carbamazepine in man.
    Rawlins MD; Collste P; Bertilsson L; Palmér L
    Eur J Clin Pharmacol; 1975 Feb; 8(2):91-6. PubMed ID: 1233212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):98-107. PubMed ID: 6341263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers.
    Stass H; Sachse R
    Clin Pharmacokinet; 2001; 40 Suppl 1():71-6. PubMed ID: 11352445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of disopyramide in normal volunteers using unbound concentration.
    Braun J; Sörgel F; Gluth WP; Oie S
    Eur J Clin Pharmacol; 1987; 32(6):625-9. PubMed ID: 3653232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefuroxime: human pharmacokinetics.
    Foord RD
    Antimicrob Agents Chemother; 1976 May; 9(5):741-7. PubMed ID: 949172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ticarcillin and ticarcillin-probenecid in sheep.
    Errecalde JO; Lanusse CE; Mestorino ON; Landoni MF; Soraci AL
    Zentralbl Veterinarmed A; 1991 May; 38(4):255-60. PubMed ID: 1907783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.
    Pentikäinen PJ; Neuvonen PJ; Backman C
    Eur J Clin Pharmacol; 1981; 19(5):359-65. PubMed ID: 7238564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.